(HealthDay)—For patients with clinically node-negative oral cavity squamous cell carcinoma, the addition of elective neck dissection to primary surgery is associated with a reduction in overall costs, according to a study ...
Aug 23, 2016
0
0
Afatinib (trade name: Giotrif) has been approved since April 2016 for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) of squamous histology who have already received chemotherapy. ...
Aug 18, 2016
0
1
Computers can be trained to be more accurate than pathologists in assessing slides of lung cancer tissues, according to a new study by researchers at the Stanford University School of Medicine.
Aug 16, 2016
0
83
(HealthDay)—Life expectancy does not appear to influence patterns of treatment for keratinocyte carcinoma (KC), according to a study published online June 15 in the Journal of the American Geriatrics Society.
Jun 20, 2016
0
0
In the first-ever clinical trial for metastatic patients previously treated for the disease, research led by The University of Texas MD Anderson Cancer Center found that the immune checkpoint blockade nivolumab shows promise ...
Jun 5, 2016
0
37
With spring and summer arriving, the air becomes warmer, the sun gets brighter and outdoor activities are more frequent. Naturally, your skin's exposure to the sun increases during this time of year, which results in a greater ...
May 13, 2016
0
17
Researchers from several major U.S. universities and ITMO University in Russia have identified a number of new driver mutations in lung cancer cells that may be responsive to genomically targeted therapies and to immunotherapy.
May 10, 2016
0
29
Loyola researchers have identified a tumor gene that may help to predict survival outcomes in patients with cancer of the mouth and tongue.
May 4, 2016
0
1
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy ...
Apr 18, 2016
0
3
Researchers on Mayo Clinic's Florida campus have shut down one of the most common and lethal forms of lung cancer by combining the rheumatoid arthritis drug auranofin with an experimental targeted agent.
Mar 14, 2016
0
20
